about
Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis.Experimental and emerging therapies for sepsis and septic shock.Immunomodulatory effects of fosfomycin in experimental human endotoxemia.Selenium supplementation in the critically ill.Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock.Effects of single dose of dexamethasone on patients with systemic inflammatory response.
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunological therapy in sepsis: currently available.
@ast
Immunological therapy in sepsis: currently available.
@en
Immunological therapy in sepsis: currently available.
@nl
type
label
Immunological therapy in sepsis: currently available.
@ast
Immunological therapy in sepsis: currently available.
@en
Immunological therapy in sepsis: currently available.
@nl
prefLabel
Immunological therapy in sepsis: currently available.
@ast
Immunological therapy in sepsis: currently available.
@en
Immunological therapy in sepsis: currently available.
@nl
P356
P1476
Immunological therapy in sepsis: currently available.
@en
P2093
International Sepsis Forum
P2888
P304
P356
10.1007/PL00003800
P478
27 Suppl 1
P577
2001-01-01T00:00:00Z